Copyright
©2008 The WJG Press and Baishideng.
World J Gastroenterol. Jun 28, 2008; 14(24): 3866-3871
Published online Jun 28, 2008. doi: 10.3748/wjg.14.3866
Published online Jun 28, 2008. doi: 10.3748/wjg.14.3866
Variable | No. or value | %1 |
Patients | 95 | |
Male | 57 | 60.0 |
Female | 38 | 40.0 |
Age (yr) | ||
Median (range) | 60.7 (24-80) | |
Primary tumour status2 | 95 | |
T1 | 1 | 1.1 |
T2 | 6 | 6.3 |
T3 | 63 | 66.3 |
T4 | 17 | 17.9 |
Tx | 8 | 8.5 |
Primary nodal status2 | 95 | |
N0 | 25 | 26.3 |
N+ | 46 | 48.4 |
Nx | 24 | 25.3 |
Metastases at diagnosis2 | 95 | |
M0 | 35 | 36.8 |
M1 | 60 | 63.2 |
Histological grade | 95 | |
Gr I | 12 | 12.6 |
Gr II | 62 | 65.3 |
Gr III | 18 | 19.0 |
NA | 3 | 3.2 |
Stage | 95 | |
Stage II | 15 | 15.8 |
Stage III | 20 | 21.0 |
Stage IV | 60 | 63.2 |
Survival (mo) | ||
From primary diagnosis Median (range) | 27.3 (3-150) | |
From metastasis Median (range) | 21.4 (3-80) |
- Citation: Elzagheid A, Buhmeida A, Korkeila E, Collan Y, Syrjänen K, Pyrhönen S. Nuclear β-catenin expression as a prognostic factor in advanced colorectal carcinoma. World J Gastroenterol 2008; 14(24): 3866-3871
- URL: https://www.wjgnet.com/1007-9327/full/v14/i24/3866.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.3866